Advertisement
Clinical Investigation| Volume 365, ISSUE 2, P176-183, February 2023

Prior cancer diagnosis and mortality profile in US adults

  • Yutang Wang
    Correspondence
    Correspondence: Yutang Wang, PhD, Discipline of Life Science, School of Science, Psychology and Sport, Federation University Australia, Ballarat, VIC 3350, Australia
    Affiliations
    Discipline of Life Science, School of Science, Psychology and Sport, Federation University Australia, Ballarat, VIC, Australia
    Search for articles by this author
  • Yan Fang
    Affiliations
    Discipline of Life Science, School of Science, Psychology and Sport, Federation University Australia, Ballarat, VIC, Australia
    Search for articles by this author
  • Christopher G. Sobey
    Affiliations
    Centre for Cardiovascular Biology and Disease Research and Department of Microbiology, Anatomy, Physiology & Pharmacology, School of Agriculture, Biomedicine & Environment, La Trobe University, Melbourne, VIC, Australia
    Search for articles by this author
  • Grant R. Drummond
    Affiliations
    Centre for Cardiovascular Biology and Disease Research and Department of Microbiology, Anatomy, Physiology & Pharmacology, School of Agriculture, Biomedicine & Environment, La Trobe University, Melbourne, VIC, Australia
    Search for articles by this author
Published:October 20, 2022DOI:https://doi.org/10.1016/j.amjms.2022.10.008

      Abstract

      Background

      Mortality profiles with multivariate adjustment in patients with a prior cancer diagnosis are scarce. This study aimed to investigate multivariate-adjusted mortality profile in US adults with a prior cancer diagnosis.

      Methods

      This cohort study included 58,109 US adults (5,016 with a prior cancer diagnosis) who attended the National Health and Nutrition Examination Survey. Mortality outcomes were ascertained by linkage to the National Death Index records. Cox proportional hazards models were used to estimate hazard ratios (HRs) and confidence intervals (CIs) of prior cancer diagnosis for mortality.

      Results

      This cohort was followed up for 646,033 person-years with a mean follow-up of 11.1 years. Compared with those without cancer, participants with a prior cancer diagnosis had increased crude cumulative mortality rates in each leading cause. Prior cancer diagnosis was associated with a higher multivariate-adjusted risk of mortality from all causes (HR, 1.29; 95% CI, 1.22-1.35), cancer (HR, 2.32; 95% CI, 2.10-2.56), and accidents (HR, 1.90; 95% CI, 1.34-2.68). Prior cancer diagnosis-associated increase in accident mortality appeared only in males and was significant only in non-Hispanic black participants. Prior cancer diagnosis-associated increase in cancer mortality appeared high in non-Hispanic black participants.

      Conclusions

      This study found that patients with a prior cancer diagnosis had higher multivariate-adjusted accident mortality risks, suggesting that oncologists may need to evaluate accident risks in cancer patients and provide preventive interventions in particular for male and non-Hispanic black patients. Increased cancer mortality risk associated with prior cancer diagnosis in non-Hispanic black participants may also need clinical attention.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bray F.
        • Ferlay J.
        • Soerjomataram I.
        • et al.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Markham M.J.
        • Wachter K.
        • Agarwal N.
        • et al.
        Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
        J Clin Oncol. 2020; 38: 1081
        • Epstein M.M.
        • Edgren G.
        • Rider J.R.
        • et al.
        Temporal trends in cause of death among Swedish and US men with prostate cancer.
        J Natl Cancer Inst. 2012; 104: 1335-1342
        • Weberpals J.
        • Jansen L.
        • Müller O.J.
        • et al.
        Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study.
        Eur Heart J. 2018; 39: 3896-3903
        • Ward K.K.
        • Shah N.R.
        • Saenz C.C.
        • et al.
        Cardiovascular disease is the leading cause of death among endometrial cancer patients.
        Gynecol Oncol. 2012; 126: 176-179
        • Salerno E.A.
        • Saint-Maurice P.F.
        • Willis E.A.
        • et al.
        Ambulatory Function and Mortality among Cancer Survivors in the NIH-AARP Diet and Health Study.
        Cancer Epidemiol Biomarkers Prev. 2021; 30: 690-698
        • Kvale E.
        • Ekundayo O.J.
        • Zhang Y.
        • et al.
        History of cancer and mortality in community-dwelling older adults.
        Cancer Epidemiol. 2011; 35: 30-36
        • Sturgeon K.M.
        • Deng L.
        • Bluethmann S.M.
        • et al.
        A population-based study of cardiovascular disease mortality risk in US cancer patients.
        Eur Heart J. 2019; 40: 3889-3897
        • Yang K.
        • Zheng Y.
        • Peng J.
        • et al.
        Incidence of Death From Unintentional Injury Among Patients With Cancer in the United States.
        JAMA Netw Open. 2020; 3e1921647
        • Zaorsky N.G.
        • Churilla T.M.
        • Egleston B.L.
        • et al.
        Causes of death among cancer patients.
        Ann Oncol. 2017; 28: 400-407
        • Oh C.M.
        • Lee D.
        • Kong H.J.
        • et al.
        Causes of death among cancer patients in the era of cancer survivorship in Korea: Attention to the suicide and cardiovascular mortality.
        Cancer Med. 2020; 9: 1741-1752
        • Harashima S.
        • Fujimori M.
        • Akechi T.
        • et al.
        Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902).
        Jpn J Clin Oncol. 2021; 51: 744-752
        • Australian Institute of Health and Welfare
        Principles on the use of direct age-standardisation in administrative data collections: for measuring the gap between Indigenous and non-Indigenous Australians.
        AIHW, Canberra2011 (Cat. no. CSI 12)
        • Wang Y.
        • Fang Y.
        Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c.
        Sci Rep. 2022; 12: 7778
        • Fang Y.
        • Wang Y.
        Fasting status modifies the association between triglyceride and all-cause mortality: A cohort study.
        Health Sci Rep. 2022; 5: e642
        • Wang Y.
        Stage 1 hypertension and risk of cardiovascular disease mortality in United States adults with or without diabetes.
        J Hypertens. 2022; 40: 794-803
        • Wang Y.
        Higher fasting triglyceride predicts higher risks of diabetes mortality in US adults.
        Lipids Health Dis. 2021; 20: 181
        • Weir C.B.
        • Jan A.
        BMI Classification Percentile And Cut Off Points. StatPearls. Treasure Island (FL).
        StatPearls Publishing LLC., 2021
        • Kim H.
        • Hu E.A.
        • Rebholz CM.
        Ultra-processed food intake and mortality in the USA: results from the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994).
        Public Health Nutr. 2019; 22: 1777-1785
        • Beddhu S.
        • Baird B.C.
        • Zitterkoph J.
        • et al.
        Physical activity and mortality in chronic kidney disease (NHANES III).
        Clin J Am Soc Nephrol. 2009; 4: 1901-1906
        • El Saadany T.
        • Richard A.
        • Wanner M.
        • et al.
        Sex-specific effects of leisure-time physical activity on cause-specific mortality in NHANES III.
        Prev Med. 2017; 101: 53-59
        • Wang Y.
        Definition, prevalence, and risk factors of low sex hormone-binding globulin in US adults.
        J Clin Endocrinol Metab. 2021; 106: e3946-e3e56
        • Grundy S.M.
        • Stone N.J.
        • Bailey A.L.
        • et al.
        2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2019; 139: e1082-ee143
        • Wang Y.
        • Fang Y.
        • Magliano D.J.
        • et al.
        Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes.
        Cardiovasc Res. 2022. Epub ahead of print; https://doi.org/10.1093/cvr/cvac124
        • Kubo Y.
        • Noguchi T.
        • Hayashi T.
        • et al.
        Eating alone and weight change in community-dwelling older adults during the coronavirus pandemic: A longitudinal study.
        Nutrition. 2022; 102111697
        • Lu D.
        • Andersson T.M.
        • Fall K.
        • et al.
        Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden.
        JAMA Oncol. 2016; 2: 1188-1196
        • National Center for Health Statistics
        Office of Analysis and Epidemiology. The Linkage of National Center for Health Statistics Survey Data to the National Death Index –2015 Linked Mortality File (LMF).
        Methodology Overview and Analytic Considerations. 2019; (Available from)
        • Menke A.
        • Muntner P.
        • Batuman V.
        • et al.
        Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults.
        Circulation. 2006; 114: 1388-1394
        • Bergmann M.M.
        • Calle E.E.
        • Mervis C.A.
        • et al.
        Validity of self-reported Cancers in a Propsective Cohort Study in Comparison with Data from State Cancer Registries.
        Am J Epidemiol. 1998; 147: 556-562